Nutriband Inc. (NASDAQ: NTRB) shares surged 10.97% in pre-market trading on Wednesday, July 2, 2025, reaching $8.90 after announcing 25% preferred dividend and FDA development focus. This marks a significant jump from the previous closing price of $8.02 recorded on the prior trading day.
Nutriband Inc. (NTRB) announced that its Board of Directors has approved and declared a 25% preferred stock dividend. Shareholders of record on July 25th, 2025, will receive one preferred share for every four shares of common stock. The pay date for shareholders to receive their new issuance will be August 5th.
Gareth Sheridan, CEO, stated they recently highlighted their Commercialization manufacturing process scale up with Kindeva (KNDV). He added that they are now laser focused on finalizing their development pathway to FDA approval.
